ArticlemedRxiv : the preprint server for health sciences2025
Mapping ADHD Heterogeneity and Biotypes through Topological Deviations in Morphometric Similarity Networks.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
14 authors.
Funding
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is characterized by considerable clinical heterogeneity. This study investigates whether normative modelling of topological properties derived from brain morphometry similarity networks can provide robust stratification markers for ADHD children. Leveraging multisite neurodevelopmental datasets (discovery: 446 ADHD, 708 controls; validation: 554 ADHD, 123 controls), we constructed morphometric similarity networks and developed normative models for three topological metrics: degree centrality, nodal efficiency, and participation coefficient. Through semi-supervised clustering, we delineated putative biotypes and examined their clinical profiles. We further contextualized brain profiles of these biotypes in terms of their neurochemical and functional correlates using large-scale databases, and assessed model generalizability in an independent cohort. ADHD exhibited atypical hub organization across all three topological metrics, with significant case-control differences primarily localized to a covarying multi-metric component in the orbitofrontal cortex. Three biotypes emerged: one characterized by severe overall symptoms and longitudinally persistent emotional dysregulation, accompanied by pronounced topological alterations in the medial prefrontal cortex and pallidum; a second by predominant hyperactivity/impulsivity accompanied by changes in the anterior cingulate cortex and pallidum; and a third by marked inattention with alterations in the superior frontal gyrus. These neural profiles of each biotype showed distinct neurochemical and functional correlates. Critically, the core findings were replicated in an independent validation cohort. Our comprehensive approach reveals three distinct ADHD biotypes with unique clinical-neural patterns, advancing our understanding of ADHD's neurobiological heterogeneity and laying the groundwork for personalized treatment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.